The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation

Vaginal cancer is a rare tumor that is optimally treated with a combination of chemotherapy (CHT) and radiation therapy. Because of the rarity of this cancer, the benefit of a brachytherapy boost (BT) and the relevance of radiotherapy time to treatment completion (TTC) are unclear.

Source: Brachytherapy - September 28, 2020 Category: Cancer & Oncology Authors: Leonid B. Reshko, Jeremy T. Gaskins, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva Source Type: research